digital therapeutics

News

Mahana raises $61m for IBS digital therapeutic

Mahana Therapeutics has raised second-round financing of $61 million that will be used to launch what it says will be the first prescription digital therapeutic (DTx) for

News

Achieving patient centricity in a digital health world

Around 250 digital health apps are launching every day, says...

There was a dramatic increase in the launch of health-related mobile applications last year, taking the total number on offer in app stories to 350,000 – and while average quality is curren

News

FDA gives breakthrough status to Biofourmis' heart failure D...

A digital therapeutic for patients with heart failure has been awarded breakthrough device status by the FDA – said by its developer Biofourmis to be the first time the US regulator h

News

Aptar makes digital health play, agreeing deal to buy Volunt...

Drug delivery specialist Aptar Group has agreed a deal to take a near two-thirds share in Voluntis, a French developer of digital therapeutics (DTx), with a view to taking full control of t

News

Happify launches Ensemble DTx for depression, anxiety in US

Happify Health has launched a prescription digital therapeutic (DTx) – called Ensemble – that can assist the treatment of people with both major depressive disorder and generalised anxiety

News

Dopavision raises €12m for DTx to tackle myopia epidemic

Digital therapeutics (DTx) startup Dopavision has raised funding to develop its lead product, an app designed to slow the progression of myopia – or short-sightedness – in children or adole

Mahana raises $61m for IBS digital therapeutic

Around 250 digital health apps are launching every day, says...

FDA gives breakthrough status to Biofourmis' heart failure D...

Aptar makes digital health play, agreeing deal to buy Volunt...

Happify launches Ensemble DTx for depression, anxiety in US

Dopavision raises €12m for DTx to tackle myopia epidemic

Getting predictive technologies to patients, with Concr

Discover a new era of healthcare panel engagement: Grounded ...

digital therapeutics

Editor's Picks